PRICE T ROWE ASSOCIATES INC /MD/ - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5
+66.7%
33,9590.0%0.00%
Q4 2022$3
-99.9%
33,959
+89.1%
0.00%
Q3 2022$3,000
-96.2%
17,954
-79.9%
0.00%
Q2 2022$79,000
-28.2%
89,354
+1.1%
0.00%
Q1 2022$110,000
-33.3%
88,371
+4.7%
0.00%
Q4 2021$165,000
+7.8%
84,371
+51.0%
0.00%
Q3 2021$153,000
-14.5%
55,871
-1.6%
0.00%
Q2 2021$179,000
+113.1%
56,771
+43.7%
0.00%
Q1 2021$84,00039,5000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders